Viewing Study NCT04305327


Ignite Creation Date: 2025-12-25 @ 5:19 AM
Ignite Modification Date: 2026-01-26 @ 10:57 PM
Study NCT ID: NCT04305327
Status: TERMINATED
Last Update Posted: 2025-03-14
First Post: 2020-03-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis
Sponsor: LEO Pharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LP0160-1396
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators